Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways (Q39564142)

13 September 2017

title

Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways (English)

1 reference

13 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

Haibo Mou

1 reference

13 September 2017

Yi Zheng

1 reference

13 September 2017

Peng Zhao

1 reference

13 September 2017

Hanying Bao

1 reference

13 September 2017

Weijia Fang

1 reference

13 September 2017

Nong Xu

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21466843

29 November 2024

publication date

3 April 2011

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0887233311000804?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

https://api.elsevier.com/content/article/PII:S0887233311000804?httpAccept=text/plain

29 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

29 November 2024

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

1027-1032

1 reference

Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors

13 September 2017

cites work

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M109.090209

Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Effects of demethylzeylasteral and celastrol on spermatogenic cell Ca2+ channels and progesterone-induced sperm acrosome reaction

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Apoptosis and cancer: the genesis of a research field

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

PI3K/Akt signalling pathway and cancer.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol causes apoptosis and cell cycle arrest in rat glioma cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

The pathophysiology of mitochondrial cell death

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Structure, regulation and function of PKB/AKT--a major therapeutic target

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Glossogin, a novel phenylpropanoid from Glossogyne tenuifolia, induced apoptosis in A549 lung cancer cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

29 November 2024

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Triterpenoids as new promising anticancer drugs.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Structural biology of the Bcl-2 family of proteins

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol: Molecular targets of Thunder God Vine

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Mechanisms of caspase activation and inhibition during apoptosis

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIV.2011.03.023

29 November 2024

Identifiers

DOI

1 reference

13 September 2017

1 reference